Back

Prophylactic use of carvedilol to prevent ventricular dysfunction in patients with cancer treated with doxorubicin

19 April 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 1 - Heart failure Chronic Heart Failure, Other EAPC Premium Access EuroPrevent 2018

6 More presentations in this session

Presentation thumbnail
Heart failure - Poster discussant:
Presentation thumbnail
Comparative risk of heart failure associated with second-line antidiabetes treatments: analysis of real-world Korean data
Doctor K. Ha (Seoul, KR)
Abstract Slides
Presentation thumbnail
Influence of pulmonary rehabilitation on clinical characteristics in patients with chronic heart failure and chronic obstructive pulmonary disease
Doctor G. Smyrnova (Kyiv, UA)
Abstract Slides
Presentation thumbnail
Aldosterone plasma level as risk factor of cardiovascular events in long-term chronic heart failure with preserved ejection fraction
Associate Professor A. Shevelyok (Donetsk, UA)
Abstract
Presentation thumbnail
The predictors of mid-term heart failure-related mortality rate: a databased analysis

Access the full session

Session thumbnail
Poster Session 1 - Heart failure

The Event

Event poster

EuroPrevent 2018

19 April - 21 April 2018

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources